Transgenic rice accumulating modified cedar pollen allergen Cry j 2 derivatives

Journal of Bioscience and Bioengineering

Volumn 113, Issue 2, 2012, Pages 249-251

  Suzuki, Kazuya ^a   Yang, Lijun ^a   Takaiwa, Fumio ^a  

^a NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

Cedar pollen allergen; Cry j 2; Pollinosis; Tolerogen; Transgenic rice

Indexed keywords

CEDAR POLLEN; CRY J 2; POLLINOSIS; TOLEROGEN; TRANSGENIC RICE;

BIOLOGY; BIOTECHNOLOGY;

ALLERGIES;

CRY J1; CRY J2; EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN E; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CEDAR POLLINOSIS; CODON; CONTROLLED STUDY; ENDOSPERM; IMMUNOBLOTTING; IMMUNOTHERAPY; JAPANESE CEDAR; NONHUMAN; POLLEN ALLERGY; RICE; TRANSGENICS;

ALLERGENS; ANTIGENS, PLANT; CRYPTOMERIA; IMMUNOGLOBULIN E; ORYZA SATIVA; PLANT PROTEINS; PLANTS, GENETICALLY MODIFIED; POLLEN; SEEDS;

EID: 84856797778     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2011.10.005     Document Type: Article

References (17)

1. Okamoto Y., Horiguchi S., Yamamoto H., Yonekura S., Hanazawa T. Present situation of cedar pollinosis in Japan and its immune responses. Allergol. Int. 2009, 58:155-162.
2. Yasueda H., Yui Y., Shimizu T., Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J. Allergy Clin. Immunol. 1983, 71:77-86.
3. Sakaguchi M., Inouye S., Taniai M., Ando S., Usui M., Matuhasi T. Identification of the second major allergen of Japanese cedar pollen. Allergy 1990, 45:309-312.
4. Bousquet J., Demoly P. Specific immunotherapy - an optimistic future. Allergy 2006, 61:1155-1158.
5. Larche M., Akdis C.A., Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 2006, 6:761-771.
6. Takaiwa F. Seed-based oral vaccines as allergen-specific immunotherapies. Hum. Vaccin. 2011, 7:357-366.
7. Takagi H., Hiroi T., Yang L., Tada Y., Yuki Y., Takamura K., Ishimitsu R., Kawauchi H., Kiyono H., Takaiwa F. A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc. Natl. Acad. Sci. USA 2005, 102:17525-17530.
8. Takagi H., Saito S., Yang L., Nagasaka S., Nishizawa N., Takaiwa F. Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine. Plant Biotechnol. J. 2005, 3:521-533.
9. Takaiwa F., Hirose S., Takagi H., Yang L., Wakasa Y. Deposition of a recombinant peptide in ER-derived protein bodies by retention with cysteine-rich prolamins in transgenic rice seed. Planta 2009, 229:1147-1158.
10. Larche M. Peptide immunotherapy for allergy diseases. Allergy 2007, 62:325-331.
11. Hirahara K., Tatsuta T., Takatori T., Ohtsuki M., Kirinaka H., Kawaguchi J., Serizawa N., Taniguchi Y., Saito S., Sakaguchi M., Inouye S., Shiraishi A. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens. J. Allergy Clin. Immunol. 2001, 108:94-100.
12. Linhart B., Valenta R. Molecular design of allergy vaccines. Curr. Opin. Immunol. 2005, 17:646-655.
13. Cromwell O., Hafner D., Nandy A. Recombinant allergens for specific immunotherapy. J. Allergy Clin. Immunol. 2011, 127:865-872.
14. Takaiwa F. Transgenic rice seed as a nutriceutical delivery system. CAB Rev. Perspect. Agric. Vet. Sci. Nutr. Nat. Resour. 2007, 2:41.
15. Schouten A., Roosien J., van Engelen F.A., de Jong G.A., Borst-Vrenssen A.W., Zilverentant J.F., Bosch D., Stiekema W.J., Gommers F.J., Schots A., Bakker J. The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cystosol and the secretory pathway in transgenic tobacco. Plant Mol. Biol. 1996, 30:781-793.
16. Hirahara K., Tatsuta T., Takatori T., Otsuka M., Kirinaka H., Kawaguchi J., Serizawa N., Taniguchi Y., Saito S., Sakaguchi M., Inouye S., Shiraishi A. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens. J. Allergy Clin. Immunol. 2001, 108:94-100.
17. Namba M., Kurose M., Torigoe K., Hino K., Taniguchi Y., Fukuda S., Usui M., Kurimoto M. Molecular cloning of the second major allergen, Cry j II, from Japanese cedar pollen. FEBS Lett. 1994, 353:124-128.